A rat model designed for the continuous intraarterial infusion of cyclosporine

J-J Fan1, L-G Cao2, L Bi1

  • 1Department of Orthopaedic Surgery, Xi Jing Hospital, Fourth Military Medical University, Xi'an, China.

Insights

Intraarterial infusion of cyclosporine (CSA) in a rat limb transplant model significantly increased drug concentrations in limb tissues compared to intravenous delivery. This targeted approach may improve drug delivery for limb allotransplantation.

Area of Science:

  • Transplantation immunology
  • Pharmacology
  • Surgical research

Background:

  • Limb allotransplantation is a non-life-saving procedure requiring high doses of immunosuppressants.
  • Current immunosuppressive strategies lack selectivity and targeted drug delivery.
  • There is a critical need for improved drug targeting in limb transplantation to minimize systemic toxicity.

Purpose of the Study:

  • To evaluate the efficacy of intraarterial (IA) infusion of cyclosporine (CSA) for targeted drug delivery in a simulated limb allotransplantation model.
  • To compare tissue and systemic drug concentrations following IA versus intravenous (IV) infusion of CSA.
  • To establish a rat hindlimb replantation model for studying IA drug delivery.

Main Methods:

  • A rat hindlimb replantation model was utilized to simulate limb allotransplantation.
  • Cyclosporine (CSA) was administered daily at 4.0 mg/kg via continuous infusion into the superficial epigastric artery (IA group) or superficial epigastric vein (IV group) of Lewis rats.
  • CSA concentrations in skin, muscle, and bone tissues of the hindlimb were measured on day 10 post-infusion.

Main Results:

  • Tissue CSA concentrations on the perfusion side were significantly higher in the IA group compared to the IV group.
  • Systemic CSA concentrations were also higher in the IA group than in the IV group.
  • Differential tissue distribution was observed, with higher concentrations in the perfused limb tissues following IA administration.

Conclusions:

  • Intraarterial infusion of CSA demonstrates superior drug distribution to limb tissues compared to intravenous infusion in this rat model.
  • These findings support further investigation of IA drug delivery strategies for limb allotransplantation.
  • Targeted IA infusion holds promise for enhancing drug efficacy and potentially reducing systemic side effects in limb transplantation.
Abstract

Related Concept Videos

One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
719
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
394
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
748
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
380
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.1K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
357